Product
Gliolan
1 clinical trial
1 indication
Indication
GlioblastomaClinical trial
Phase I/II Dose Escalation Trial of Radiodynamic Therapy (RDT) With 5-Aminolevulinic Acid in Patients With First Recurrence of GlioblastomaStatus: Recruiting, Estimated PCD: 2024-07-01